Five-locus HLA typing of hematopoietic stem cell donor volunteers using PCR sequence specific primers

Genetic Testing

Volumn 8, Issue 3, 2004, Pages 301-312

  Downing, J ^a   Guttridge, M G ^b   Thompson, J ^a   Darke, C ^a  

^a Welsh Blood Service   (United Kingdom)

^b NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; ARTICLE; BLOOD GROUP ABO SYSTEM; CONTROLLED STUDY; GENE LOCUS; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA TYPING; HUMAN; POLYMERASE CHAIN REACTION; SEROLOGY; WORLD HEALTH ORGANIZATION;

EID: 2342597394     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2004.8.301     Document Type: Article

References (36)

1. ALDENER-CANNAVA, A., and OLERUP, O. (2001). HLA-DPB1 typing by polymerase chain reaction amplification with sequence-specific primers. Tissue Antigens 57, 287-299.
2. BODMER, J.G., MARSH, S.G.E., ALBERT E.D., BODMER, W.F., DUPONT, B., ERLICH, H.A., MACH, B., MAYR, W.R., PARHAM, P., SASAZUKI, T., SCHREUDER, G.M.TH., STROMINGER, J.L., SVEJGAARD, A., and TERASAKI, P.I. (1992). Nomenclature for factors of the HLA system, 1991. Tissue Antigens 39, 161-173.
3. BUNCE, M., O'NEILL, C.M., BARNARDO, M.C.N.M., KRAUSA, P., BROWNING, M.J., MORRIS, P.J., and WELSH, K.I. (1995). Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46, 355-367.
4. BUNCE, M., BARNARDO, M.C., PROCTER, J., MARSH, S.G., VILCHES, C., and WELSH, K.K. (1996). High resolution HLA-C typing by PCR-SSP: identification of allelic frequencies and linkage disequilibria in 604 unrelated random UK Caucasoids and a comparison with serology. Tissue Antigens 48, 680-691.
5. CURRAN, M.D., WILLIAMS, F., LITTLE, A.-M., RIMA, B.K., MADRIGAL, J.A., and MIDDLETON, D. (1999). Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele. Tissue Antigens 53, 244-252.
6. DARKE, C. (2000). An overview of the Welsh Bone Marrow Donor Registry: 10 years of bone marrow donor provision. Bone Marrow Transplant. 25, 771-777.
7. DARKE, C., and DYER, P.A. (1993). Clinical HLA typing by cytotoxicity. In Histocompatibility Testing: A Practical Approach. P.A. Dyer, and D. Middleton (eds.). IRL Press Practical Approach Series, Oxford, pp. 51-80.
8. DARKE, C., GUTTRIDGE, M.G., THOMPSON, J., McNAMARA, S., STREET, J., and THOMAS, M. (1998a). HLA class I (A, B) and II (DR, DQ) gene and haplotype frequencies in blood donors from Wales. Exp. Clin. Immunogenet. 15, 69-83.
9. DARKE, C., GUTTRIDGE, M.G., THOMPSON, J., STREET, J., and THOMAS, M. (1998b). Molecular, serological and population studies on a novel HLA-B allele - HLA-B*5002. Tissue Antigens 51, 666-670.
10. DARKE, C., GUTTRIDGE, M.G., STREET, J., THOMPSON, J., and THOMAS, M. (1999). HLA-B*4703: sequence confirmation, serology and distribution. Tissue Antigens 53, 586-590.
11. DARKE, C., GUTTRIDGE, M.G., STREET, J., THOMPSON, J., and THOMAS, M. (2000). Molecular, serological and genetic studies on two new HLA-DRB1 alleles - DRB1*0704 and HLA-DRB1*1507. Tissue Antigens 56, 467-469.
12. DARKE, C., STREET, J., HAMMOND, L., DOWNING, J., and THOMPSON, J. (2002). Immunogenetic study of a new HLA allele - HLA-B*2723. Tissue Antigens 60, 400-403.
13. DOWNING, J., and DARKE, C. (2003). A modified PCR-SSP method for the identification of ABO blood group antigens. Eur. J. Immunogenet. 30, 295-298
14. EN ISO 9001:2000. (2000). Quality Management systems - requirements. ISO.
15. GRUNDSCHOBER, C., RUFER, N., SANCHEZ-MAZAS, A., MADRIGAL, A., JEANNET, M., ROOSNEK, E., and TIERCY, J.-M. (1997). Molecular characterization of HLA-C incompatibilities in HLA-ABDR-matched unrelated bone marrow donor-recipient pairs. Tissue Antigens 49, 612-623.
16. GUTTRIDGE, M.G., and DARKE, C. (2001). Identification and nucleotide sequence of HLA-A*03013. Tissue Antigens 57, 546-547.
17. GUTTRIDGE, M.G., STREET, J., THOMAS, M., and DARKE, C. (1999). Identification of HLA-A*0224: implications for PCR-SSP HLA typing. Tissue Antigens 53, 190-193.
18. GUTTRIDGE, M.G., CARTER, K., WORWOOD, M., and DARKE, C. (2000) Population screening for hemochromatosis by PCR using sequence specific primers. Genet. Test. 4, 111-114.
19. HELMBERG, W., LANZER, G., ZAHN, R., WEINMAYER, B., WAGNER, T., and ALBERT, E. (1998). Virtual DNA analysis - a new tool for combination and standardisation evaluation of SSO, SSP and sequence-based typing results. Tissue Antigens 51, 587-592.
20. HURLEY, C.K., WADE, J.A., OUDSHOORN, M., MIDDLETON, D., KUKURUGA, D., NAVARRETE, C., CHRISTIANSEN, F., HEGLAND, J., REN, E., ANDERSEN, I., CLEAVER, S.A., BRAUTBAR, C., and RAFFOUX, C. (1999). A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Tissue Antigens 53, 394-406.
21. KAMINSKI, E.R. (1989). How important is histocompatibility in bone marrow transplantation? Bone Marrow Transplant. 4, 439-444.
22. LAU, M., TERASAKI, P.I., and PARK, M.S. (1994). International Cell Exchange, 1994. In Clinical Transplants 1994. P.I. Terasaki and J.M. Cecka (eds.). UCLA Tissue Typing Laboratory. Los Angeles, pp. 467-488.
23. LI, X.Y., LIU, J.Z., and GAO, S.Z. (2001). Determination of a real-time fluorotyping strategy for the HLA-DR locus. Transplant Proc. 33, 498-499.
24. LITTLE, A.-M., and MADRIGAL, J.A. (1999). Molecular matching in allogeneic bone marrow transplantation. J. Immunogenet. 26, 35-41.
25. MARSH, S.G.E., BODMER, J.G., ALBERT, E.D., BODMER, W.F., BONTROP, R.E., DUPONT, B., ERLICH, H.A., HANSEN, J.A., MACH, B., MAYR, W.R., PARHAM, P., PETERSDORF, E.W., SASAZUKI, T., SCHREUDER, G.H.TH., STROMIGER, J.L., SVEJGAARD, A., and TERASAKI, P.I. (2001). Nomenclature for factors of the HLA system, 2000. Tissue Antigens 57, 236-283.
26. NOREEN, H.J., YU, N., SETTERHOLM, M., OHASHI, M., BAISCH, J., ENDRES, R., FERNANDEZ-VINA, M., HEINE, U., HSU, S., KAMOUN, M., MITSUISHI, Y., MONOS, D., PERLEE, L., RODRIGUEZ-MARINO, S., SMITH, S., YANG, S.Y., SHIPP, K., HEGLAND, J., and HURLEY, C.K. (2001). Validation of DNA-based HLA-A and HLA-B testing of volunteers for a bone marrow registry through parallel testing with serology. Tissue Antigens 57, 221-229.
27. OLERUP, O., and ZETTERQUIST, H. (1992). HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39, 225-235.
28. OLERUP, O., ALDENER, A., and FOGDELL, A. (1993). HLA-DQB1 and DQAI typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours. Tissue Antigens 41, 119-134.
29. PETERSDORF, E.W., LONGTON, G.M., ANASETTI, C., MICKELSON, E.M., MCKINNEY, S.K., SMITH, A.C., MARTIN, P.J., and HANSEN, J.A. (1997). Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 89, 1818-1823.
30. SCHAFFER, M., and OLERUP, O. (2001). HLA-AB typing by polymerase-chain reaction with sequence-specific primers: more accurate, less errors, and increased resolution compared to serological typing. Tissue Antigens 58, 299-307.
31. SCOTT, I., O'SHEA, J., BUNCE, M., TIERCY, J.M., ARGUELLO, J.R., FIRMAN, H., GOLDMAN, J., PRENTICE, H.G., LITTLE, A.-M., and MADRIGAL, J.A. (1998). Molecular typing shows a high level of HLA class 1 incompatibility in serologically well matched donor/patient pairs: implications for unrelated bone marrow donor selection. Blood 92, 4864-4871.
32. STREET, J., DOWNING, J., HAMMOND, L., THOMPSON, J., and DARKE, C. (2002). Immunogenetics of two new HLA alleles: A*0108 and B*4031. Tissue Antigens 61, 322-324.
33. STREET, J., HAMMOND, L., DOWNING, J., THOMPSON, J., and DARKE, C. (2003) Observations on the HLA-A2403 specificity. Tissue Antigens 61, 330-333.
34. TIEMANN, C., VOGEL, A., DUFAUX, B., ZIMMER, M., KRONE, J.R., and HAGEDORN, H.J. (2001). Rapid DNA typing of HLA-B27 allele by real-time PCR using lightcycler technology. Clin. Lab. 47, 131-134.
35. THOMPSON, J. (1995). "The development of a DNA-based method for the detection of HLA-Cw alleles using Restriction Fragment Length Polymorphism (RFLP) and Polymerase Chain Reaction with Sequence Specific Primers (PCR-SSP). A disease study of 22 retroperitoneal fibrosis patients and a possible association with HLA-Cw7." M.Sc. Thesis, University Wales Institute, Cardiff.
36. UK National External Quality Assessment Schemes for Histocompatibility and Immunogenetics Annual Report 2000. (2001). UK NEQAS for H&I, Pontyclun, U.K.